NCT07459647: A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- State
- Under way
- Phase
- Phase 2
- People
- 500 planned
- Started
- 31 Mar 2026
- Primary completion
- Feb 2030
- Arms
- ML-007C-MA
- Results
- None posted
- 10 Mar 2026: Trial registered
- 31 Mar 2026: Trial started